Posts by Leland G. Richardson, MMSc, MS
-
Review: Implications of IDH Mutations for Success of Glioma Immunotherapy
Neuroscience researchers at Massachusetts General Hospital recently reviewed the latest data on the tumor immune microenvironment of IDH-mutant glioma, the role of 2-hydroxyglutarate as a regulator of glioma immune evasion, and novel immunotherapeutic strategies that are being investigated in early clinical trials.
Biography
Leland G. Richardson, MMSc, MS, is a graduate student in the Translational Brain Tumor Immunology Lab at Massachusetts General Hospital.
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.